Literature DB >> 11983300

Cortical neurons of Creutzfeldt-Jakob disease patients express the urokinase-type plasminogen activator receptor.

M H Deininger1, K Trautmann, V Magdolen, T Luther, H J Schluesener, R Meyermann.   

Abstract

Plasminogen belongs to the plasminogen activator system of cell signaling proteins and has recently been identified to bind to pathological prion protein PrPSC, but not to its normal conformer, PrPC. Plasminogen binds specifically to the urokinase-type plasminogen activator receptor (uPAR) to promote pericellular proteolysis, regulate integrin function, and mediate cell signaling. By using immunohistochemistry, we observed that significantly more cortical neurons in eight postmortem brains of patients who died with sporadic Creutzfeldt-Jakob disease (CJD) are immunoreactive for uPAR compared with controls. These data provide the pathophysiological basis for detailed analyses of the role of the plasminogen activator system in CJD and related diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983300     DOI: 10.1016/s0304-3940(02)00168-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.

Authors:  Kristen Hatcher; Jian Zheng; Shu G Chen
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions.

Authors:  Younghwan Kim; Jihyun Song; Charles E Mays; William Titlow; Donghoon Yoon; Chongsuk Ryou
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

3.  Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.

Authors:  Xavier Ekolle Ndode-Ekane; Asla Pitkänen
Journal:  Mol Neurobiol       Date:  2012-12-21       Impact factor: 5.590

4.  Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases.

Authors:  Manuela Nebuloni; Paola Cinque; Nicolai Sidenius; Angelita Ferri; Eleonora Lauri; Elisabetta Omodeo-Zorini; Pietro Zerbi; Luca Vago
Journal:  J Neurovirol       Date:  2008-12-24       Impact factor: 2.643

5.  Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.

Authors:  Eva Haastrup; Katrine Grau; Jesper Eugen-Olsen; Christian Thorball; Lars Vedel Kessing; Henrik Ullum
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 6.  Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

Authors:  V M Baart; R D Houvast; L F de Geus-Oei; P H A Quax; P J K Kuppen; A L Vahrmeijer; C F M Sier
Journal:  EJNMMI Res       Date:  2020-07-28       Impact factor: 3.138

7.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.